Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.


CSE:BRAX - Post by User

Comment by CyberSecurityon Apr 23, 2021 3:04pm
212 Views
Post# 33056647

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Recommence Trading SHRM 𓋼🤑𓋼 CLOSE $2+ ?! =>

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Recommence Trading SHRM 𓋼🤑𓋼 CLOSE $2+ ?! =>Yes and Financials will be out very shortly for quarter. The potential upside of SHRM weighs heavy over many other mushroom tickers such as TRIP & MMED. In my opinion MMED is extremely over valued, as the tech behind comp doesn't equate to the share price.
Korcan wrote: Yes, when you look at it that way the share price should be much higher than it is. It's weird that the SHRM is the only stock  in this area but is actually making money? The rest of them are just running on good news and hype.


<< Previous
Bullboard Posts
Next >>